CORC

浏览/检索结果: 共2条,第1-2条 帮助

限定条件        
已选(0)清除 条数/页:   排序方式:
Clinical outcomes of patients with or without common AEs in anlotinib cohort: Subgroup analysis of the ALTER0303 trial. 会议论文
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019
作者:  Wang Zhe-Hai;  Han, Baohui;  Li, Kai;  Cheng, Ying;  Liu, Jie
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/31
The efficacy of anlotinib in squamous cell carcinoma (SCC) patients with or without hypertension in ALTER0303: Anlotinib as a third-line therapy in patients with advanced non-small cell lung cancer (NSCLC). 会议论文
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019
作者:  Shi, Jianhua;  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/31


©版权所有 ©2017 CSpace - Powered by CSpace